• Mashup Score: 28

    This session will not be live-streamed. Participation only on-site. This session will not be live-streamed. Participation only

    Tweet Tweets with this article
    • In #GU, as well all tracks (took a peek, abstracts released), this is going to be a very busy and rich #ESMO23!! Cannot miss it! @Silke_Gillessen @APassaroMD @AndresC27622123 @KKronig @MyriamChalabi https://t.co/2cgbxhP8yG

    • #ESMO23 @myESMO starts this week in #Madrid!! Here is what you need to watch out for (I think) in the #GU space: @OncoAlert @urotoday @DanaFarber_GU @OncBrothers @Uromigos @OncLive @TargetedOnc @PeerView @ESMO_Open @Annals_Oncology https://t.co/2cgbxhP8yG https://t.co/QjMZeFlac1

  • Mashup Score: 1

    Uromigos Live 2023 will take place in Nashville November 3-4, 2023. More details coming soon! …

    Tweet Tweets with this article
    • ⌛️#Uromigoslive is almost here➡️Join @Uromigos November 3rd and 4th in Nashville. 👉Livestreams, podcasts, videos, and lots of great content by leaders in the #GU field. For more details➡️https://t.co/yhL1OMk6cg Today we start with our ‼️ #ProstateCancer Polls ‼️ (1/3) https://t.co/88EKnYJX2v

  • Mashup Score: 1

    Nataliya Mar, MD Clinical Associate Professor in the Division of Hematology/Oncology at the University of California Irvine, provides GU ASCO Updates [2023]. What were the VESPER trial results?  What were the CONTACT-03 trial results?  In the case of the 68-year-old man with metastatic prostate cancer, who…

    Tweet Tweets with this article
    • 📢 GU ASCO Updates [2023] Interview - Nataliya Mar, MD MOASC 🩺 Dive into oncology treatment with Dr. Nataliya Mar! Watch the insightful interview 📽️ [video]https://t.co/dXRZyBNblm. ✅ Vesper, Contact-03, and Talapro Pro results.💪@ASCO @MOASC_Office @UCIrvine #GU #Oncology https://t.co/AvfQZak7vF

  • Mashup Score: 1

    Survivors of testicular cancer often have undetected risk factors for cardiovascular disease that can lead to worse quality of life, according to data published in Journal of Clinical Oncology.Having obesity or smoking at the beginning of treatment, as well as the development of Raynaud’s phenomenon or dyslipidemia after treatment or a family history of cardiovascular disease, appeared

    Tweet Tweets with this article
    • Testicular cancer survivors often have undetected cardiovascular disease risk factors that can worsen quality of life, data in @JCO_ASCO show. https://t.co/1rUfoGTPNz @univgroningen #hearthealth #cardiooncology #GU #GUCancer #Genitourinary

  • Mashup Score: 0
    The Cancer News Daily - 1 year(s) ago

    The latest in cancer medicine and translational research by Wafik El-Deiry MDPhD

    Tweet Tweets with this article
    • The latest The Cancer News Daily! https://t.co/Ft4rLPrxOp Thanks to @Aiims1742 @ecancer @CancerNetwrk #gu #kidneycancer

  • Mashup Score: 18

    It is with great sadness and a heavy heart that we announce the passing of Dr. Anil Kapoor. Dr. Kapoor passed away in the early hours of February 28 after a short and courageous battle with an acute illness. His loss is deeply felt by the entire urologic… | News Page

    Tweet Tweets with this article
    • I am just trying to process the news. The #GU community has lost a giant in the field. This will be deeply felt by the entire urologic and #KidneyCancer community worldwide. https://t.co/VhgGpGGSgg @kidneycan @KidneyCancer @kcCURE @lalaniMD @McMasterU @KidneyCancer_Ca https://t.co/dDHBTJ5uFh https://t.co/m7AYJakvU1